有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | N-(1-cyanocyclohexyl)-4-phenylsulfanylbutanamide | —— | C17H22N2OS |
|
—— | N-butyl-N-[(3R)-1,1-dioxothiolan-3-yl]-3-phenylsulfanylpropanamide | —— | C17H25NO3S2 |
|
—— | [(2R)-1-[(4-methylphenyl)methylamino]-1-oxopropan-2-yl] 2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetate | —— | C19H23N3O3S |
|
—— | 2-(2,5-dimethylphenyl)sulfanyl-N-[(S)-phenyl(pyridin-2-yl)methyl]acetamide | —— | C22H22N2OS |
|
—— | (2S)-N-cyclohexyl-N-ethyl-2-[(5-methylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]propanamide | —— | C14H23N3OS3 |
|
—— | (2R)-2-[(4-amino-5-tert-butyl-1,2,4-triazol-3-yl)sulfanyl]-N-cyclohexyl-N-methylpropanamide | —— | C16H29N5OS |
|
—— | (2S)-2-[(4-amino-5-tert-butyl-1,2,4-triazol-3-yl)sulfanyl]-N-cyclohexyl-N-methylpropanamide | —— | C16H29N5OS |
|
—— | (2S)-2-(4-amino-6-methylpyrimidin-2-yl)sulfanyl-N-(2,2,2-trifluoroethyl)propanamide | —— | C10H13F3N4OS |
|
—— | (2R)-N-cyclohexyl-N-ethyl-2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C20H27N3O2S |
|
—— | (2R)-N-benzyl-N-methyl-2-[(5-methylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]propanamide | —— | C14H17N3OS3 |
|
—— | (2S)-N-[2-(cyclohexen-1-yl)ethyl]-2-[(5-methylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]propanamide | —— | C14H21N3OS3 |
|
—— | (2R)-N-cyclohexyl-N-ethyl-2-[(5-methylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]propanamide | —— | C14H23N3OS3 |
|
—— | 2-(4-chlorophenyl)sulfanyl-N-[(3R)-1,1-dioxothiolan-3-yl]-N-ethylacetamide | —— | C14H18ClNO3S2 |
|
—— | (2R)-N-[(3-fluorophenyl)methyl]-N-methyl-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]propanamide | —— | C14H16FN3OS2 |
|
—— | (2S)-N-benzyl-N-methyl-2-[(5-methylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]propanamide | —— | C14H17N3OS3 |
|
—— | (2S)-N-cyclohexyl-N-ethyl-2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C20H27N3O2S |
|
—— | (2R)-N-[2-(cyclohexen-1-yl)ethyl]-2-[(5-methylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]propanamide | —— | C14H21N3OS3 |
|
—— | N-[(3R)-1,1-dioxothiolan-3-yl]-2-phenylsulfanyl-N-propylacetamide | —— | C15H21NO3S2 |
|
—— | 2-(2,5-difluorophenyl)sulfanyl-N-[2-(3-fluorophenyl)ethyl]acetamide | —— | C16H14F3NOS |
|
—— | [(2S)-1-[[(3S)-1,1-dioxothiolan-3-yl]amino]-1-oxopropan-2-yl] 2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetate | —— | C15H21N3O5S2 |
|
—— | (2S)-2-[[4-(3-methoxypropyl)-5-oxo-1H-1,2,4-triazol-3-yl]sulfanyl]-3-(4-methylphenyl)propanenitrile | —— | C16H20N4O2S |
|
—— | [(2R)-1-[(2-chlorophenyl)methylamino]-1-oxopropan-2-yl] 2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetate | —— | C18H20ClN3O3S |
|
—— | [(2S)-1-oxo-1-(prop-2-enylamino)propan-2-yl] 2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetate | —— | C14H19N3O3S |
|
—— | 3-(4,6-dimethyl-2-methylsulfanylpyrimidin-5-yl)-N-[2-(3-fluorophenyl)ethyl]propanamide | —— | C18H22FN3OS |
|
—— | [(2R)-1-[[(3S)-1,1-dioxothiolan-3-yl]amino]-1-oxopropan-2-yl] 2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetate | —— | C15H21N3O5S2 |
|
—— | [(2S)-1-(cycloheptylamino)-1-oxopropan-2-yl] 2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetate | —— | C18H27N3O3S |
|
—— | [(2S)-1-[[(3R)-1,1-dioxothiolan-3-yl]amino]-1-oxopropan-2-yl] 2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetate | —— | C15H21N3O5S2 |
|
—— | [(2R)-1-[(4-fluorophenyl)methylamino]-1-oxopropan-2-yl] 2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetate | —— | C18H20FN3O3S |
|
—— | 2-[[5-[(5R)-5-tert-butyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]-1,3,4-oxadiazol-2-yl]sulfanyl]ethanol | —— | C16H22N2O2S2 |
|
—— | (2R)-2-(4-amino-6-methylpyrimidin-2-yl)sulfanyl-N-(2,2,2-trifluoroethyl)propanamide | —— | C10H13F3N4OS |
|
—— | N-[(S)-phenyl(pyridin-4-yl)methyl]-2-pyridin-4-ylsulfanylacetamide | —— | C19H17N3OS |
|
—— | 4-amino-3-[(3,4-difluorophenyl)methylsulfanyl]-6-methyl-1,2,4-triazin-5-one | —— | C11H10F2N4OS |
|
—— | 3-[(3,4-Difluorophenyl)methylsulfanyl]-5-(furan-2-yl)-4-methyl-1,2,4-triazole | —— | C14H11F2N3OS |
|
—— | 2-(3,4-dimethylphenyl)sulfanyl-N-[2-(3-fluorophenyl)ethyl]acetamide | —— | C18H20FNOS |
|
—— | N-[2-(3-fluorophenyl)ethyl]-2-(4-methylphenyl)sulfanylacetamide | —— | C17H18FNOS |
|
—— | (2R)-N-cyclopropyl-2-[5-(trifluoromethyl)pyridin-2-yl]sulfanylpropanamide | —— | C12H13F3N2OS |
|
—— | N-[2-(3-fluorophenyl)ethyl]-2-(2-methylphenyl)sulfanylacetamide | —— | C17H18FNOS |
|
—— | 2-(4-bromophenyl)sulfanyl-N-[2-(3-fluorophenyl)ethyl]acetamide | —— | C16H15BrFNOS |
|
—— | 4-amino-3-(3-hydroxypropylsulfanyl)-6-methyl-1,2,4-triazin-5-one | —— | C7H12N4O2S |
|
—— | 4-amino-6-methyl-3-(3-phenylpropylsulfanyl)-1,2,4-triazin-5-one | —— | C13H16N4OS |
|
—— | 4-amino-6-methyl-3-(2-phenylethylsulfanyl)-1,2,4-triazin-5-one | —— | C12H14N4OS |
|
—— | [(3S)-3-cyano-4-imino-2-oxopentyl] 3-(4,6-dimethyl-2-methylsulfanylpyrimidin-5-yl)propanoate | —— | C16H20N4O3S |
|
—— | 2-methylsulfanylethyl 2-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanyl]acetate | —— | C13H17N3O3S2 |
|
—— | 5-(Pyrimidin-2-ylsulfanylmethyl)-3-thiophen-2-yl-1,2,4-oxadiazole | —— | C11H8N4OS2 |
|
—— | N-[3-(3,5-dimethylpyrazol-1-yl)propyl]-2-pyrimidin-2-ylsulfanylacetamide | —— | C14H19N5OS |
|
—— | 2-(2,5-Dimethylfuran-3-yl)-5-(pyrimidin-2-ylsulfanylmethyl)-1,3,4-oxadiazole | —— | C13H12N4O2S |
|
—— | 3-(furan-2-yl)-4-methyl-5-[(1S)-1-phenylethyl]sulfanyl-1,2,4-triazole | —— | C15H15N3OS |
|
—— | 3-(furan-2-yl)-4-methyl-5-[(1R)-1-phenylethyl]sulfanyl-1,2,4-triazole | —— | C15H15N3OS |
|
—— | methyl (2R)-2-[[4-(2-methoxyethyl)-1,2,4-triazol-3-yl]sulfanyl]propanoate | —— | C9H15N3O3S |
|
—— | pyridin-2-ylmethyl 2-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanyl]acetate | —— | C16H16N4O3S |
|